Body Mass Index and the Association with Vaso-occlusive Crises in Pediatric Sickle Cell Disease

Journal of Pediatric Hematology/Oncology

Volumn 39, Issue 4, 2017, Pages 314-317

  Zivot, Andrea ^a   Apollonsky, Nataly ^b   Gracely, Edward ^c   Raybagkar, Deepti ^b  

^a Department of Radiology   (United States)

^b ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

^c DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

obesity; pediatric; sickle cell disease; vaso occlusive crisis

Indexed keywords

CALCIFEDIOL; HEMOGLOBIN; HYDROXYUREA; NARCOTIC ANALGESIC AGENT;

ADOLESCENT; ADULT; ARTICLE; BLOOD PRESSURE; BLOOD TRANSFUSION; BODY MASS; BODY WEIGHT; CARDIOVASCULAR PARAMETERS; CHILD; COMORBIDITY; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MALE; MENTAL DISEASE; MIGRAINE; NEWBORN; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SICKLE CELL ANEMIA; SLEEP DISORDERED BREATHING; TRICUSPID REGURGITANT VELOCITY; VEIN OCCLUSION; ARTERIAL OCCLUSIVE DISEASES; COMPLICATION; HOSPITALIZATION; OBESITY; PAIN; PATHOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; YOUNG ADULT;

ADOLESCENT; ANALGESICS, OPIOID; ANEMIA, SICKLE CELL; ARTERIAL OCCLUSIVE DISEASES; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; OBESITY; PAIN; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 85013478477     PISSN: 10774114     EISSN: 15363678     Source Type: Journal    
DOI: 10.1097/MPH.0000000000000787     Document Type: Article

References (30)

1. Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ. 2008;86:480-487.
2. Quinn CT. Sickle cell disease in childhood: from newborn screening through transition to adult medical care. Pediatr Clin North Am. 2013;60:1363-1381.
3. Du E, Diez-Silva M, Kato GJ, et al. Kinetics of sickle cell biorheology and implications for painful vasoocclusive crisis. Proc Natl Acad Sci U S A. 2015;112:1422-1427.
4. Miller ST, Sleeper LA, Pegelow CH, et al. Prediction of adverse outcomes in children with sickle cell disease. N Engl J Med. 2000;342:83-89.
5. Quinn CT, Lee NJ, Shull EP, et al. Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort. Blood. 2008;111:544-548.
6. Platt OS, Thorington BD, Brambilla DJ, et al. Pain in sickle cell disease. Rates and risk factors. N Engl J Med. 1991;325: 11-16.
7. Gill FM, Sleeper LA, Weiner SJ, et al. Clinical events in the first decade in a cohort of infants with sickle cell disease. cooperative study of sickle cell disease. Blood. 1995;86: 776-783.
8. Darbari DS, Onyekwere O, Nouraie M, et al. Markers of severe vaso-occlusive painful episode frequency in children and adolescents with sickle cell anemia. J Pediatr. 2012;160:286-290.
9. Kato GJ, McGowan V, Machado RF, et al. Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease. Blood. 2006;107:2279-2285.
10. Heyman MB, Vichinsky E, Katz R, et al. Growth retardation in sickle-cell disease treated by nutritional support. Lancet (London, England). 1985;1:903-906.
11. Wang WC, Morales KH, Scher CD, et al. Effect of long-term transfusion on growth in children with sickle cell anemia: results of the STOP trial. J Pediatr. 2005;147:244-247.
12. Fung EB, Barden EM, Kawchak DA, et al. Effect of hydroxyurea therapy on resting energy expenditure in children with sickle cell disease. Pediatr Hematol Oncol. 2001;23:604-608.
13. Zemel BS, Kawchak DA, Ohene-Frempong K, et al. Effects of delayed pubertal development, nutritional status, and disease severity on longitudinal patterns of growth failure in children with sickle cell disease. Pediatr Res. 2007;61(pt 1):607-613.
14. Mitchell MJ, Carpenter GJ, Crosby LE, et al. Growth status in children and adolescents with sickle cell disease. Pediatr Hematol Oncol. 2009;26:202-215.
15. Platt OS, Rosenstock W, Espeland MA. Influence of sickle hemoglobinopathies on growth and development. N Engl J Med. 1984;311:7-12.
16. Modebe O, Ifenu SA. Growth retardation in homozygous sickle cell disease: role of calorie intake and possible genderrelated differences. Am J Hematol. 1993;44:149-154.
17. Kawchak DA, Schall JI, Zemel BS, et al. Adequacy of dietary intake declines with age in children with sickle cell disease. J Am Diet Assoc. 2007;107:843-848.
18. Hibbert JM, Hsu LL, Bhathena SJ, et al. Proinflammatory cytokines and the hypermetabolism of children with sickle cell disease. Exp Biol Med (Maywood). 2005;230:68-74.
19. Chawla A, Sprinz PG, Welch J, et al. Weight status of children with sickle cell disease. Pediatrics. 2013;131:e1168-e1173.
20. Barden EM, Zemel BS, Kawchak DA, et al. Total and resting energy expenditure in children with sickle cell disease. J Pediatr. 2000;136:73-79.
21. Robbins JM, Mallya G, Wagner A, et al. Prevalence, disparities, and trends in obesity and severe obesity among students in the school district of Philadelphia, PA, 2006-2013. Prev Chronic Dis. 2015;12:E134.
22. Pells JJ, Presnell KE, Edwards CL, et al. Moderate chronic pain, weight and dietary intake in African-American adult patients with sickle cell disease. J Natl Med Assoc. 2005;97:1622-1629.
23. Bhattacharjee R, Kim J, Kheirandish-Gozal L, et al. Obesity and obstructive sleep apnea syndrome in children: a tale of inflammatory cascades. Pediatr Pulmonol. 2011;46:313-323.
24. Tauman R, Gozal D. Obesity and obstructive sleep apnea in children. Paediatr Respir Rev. 2006;7:247-259.
25. Hargrave DR, Wade A, Evans JP, et al. Nocturnal oxygen saturation and painful sickle cell crises in children. Blood. 2003;101:846-848.
26. Raphael JL, Mei M, Mueller BU, et al. High resource hospitalizations among children with vaso-occlusive crises in sickle cell disease. Pediatr Blood Cancer. 2012;58:584-590.
27. Xu S, Xue Y. Pediatric obesity: causes, symptoms, prevention and treatment. Exp Ther Med. 2016;11:15-20.
28. Forno E. Childhood obesity and asthma: To BMI or not to BMI? J Allergy Clin Immunol. 2016. [Epub ahead of print].
29. Ranque B, Menet A, Boutouyrie P, et al. Arterial stiffness impairment in sickle cell disease associated with chronic vascular complications: The Multinational African CADRE Study. Circulation. 2016;134:923-933.
30. Levenson JL, McClish DK, Dahman BA, et al. Depression and anxiety in adults with sickle cell disease: the PiSCES project. Psychosom Med. 2008;70:192-196.